Indication

Giant cell tumor of bone

Giant cell tumor of bone is a rare, benign primary osteolytic neoplasm characterized by local aggressiveness and marked bone destruction. Read more about Giant cell tumor of bone

8 drugs 8 manufacturers

Advertisement

Drugs that treat it

Common Giant cell tumor of bone therapies.

Showing 1–8 of 8 drugs

Filter & compare in the drug finder →Opens the drug finder with Giant cell tumor of bone preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Giant cell tumor of bone.

Giant cell tumor of bone is a rare, benign primary osteolytic neoplasm characterized by local aggressiveness and marked bone destruction.

It predominantly affects young and middle-aged skeletally mature adults, most commonly presenting in the third and fourth decades of life with a slight female predominance.

Pathophysiologically, the tumor arises in the epiphyseal-metaphyseal regions of long bones—most frequently around the knee in the distal femur and proximal tibia—and is histopathologically defined by proliferating neoplastic mononuclear stromal cells that recruit numerous reactive, osteoclast-like multinucleated giant cells.

Although histologically nonmalignant, it frequently causes localized cortical thinning, pathological fractures, and joint pain, exhibiting a high potential for local recurrence and rare pulmonary metastasis.

Personalize your experience

Follow Giant cell tumor of bone and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it